Klinikum Nürnberg

Curriculum Internistische Intensivmedizin (2021) John S, Riessen R, Karagiannidis C, Janssens U, Busch H, Kochanek M, Michels G, et al. Journal article, Review article Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany (2020) Engelhardt M, Shoumariyeh K, Roesner A, Ihorst G, Biavasco F, Meckel K, Von Metzler I, et al. Journal article The Value of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with and without ASXL1-, RUNX1- and TP53 Mutations (2020) Heidrich K, Middeke JM, Schaefer-Eckart K, Aulitzky WE, Einsele H, Mueller-Tidow C, Rösler W, et al. Conference contribution Sharing of decision-making for infective endocarditis surgery: a narrative review of clinical and ethical implications (2020) Pollari F, Spadaccio C, Cuomo M, Chello M, Nenna A, Fischlein T, Nappi F Journal article, Review article Predictive Value of VIBE using Subtraction to Evaluate Idiopathic Facial Palsy after Starting Therapy (2020) Tomita H, Detmar K, Manava P, Nakajima Y, Lell M, Adamus R Journal article Qualitätssicherungsrichtlinie Früh- und Reifgeborene des Gemeinsamen Bundesausschusses als Qualitätsrisiko? Analyse zu Erfüllungsgrad und Konsequenzen in der Versorgung weiterer intensivpflichtiger Patienten sowie drohender Frühgeburten am Beispiel eines regionalen Verbund-Perinatalzentrums (2020) Kleeberg M, Beckmann M, Fusch C, Hanf V, Kainer F, Klinge J, Koehler W, et al. Journal article Allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia with ASXL1-, RUNX1- and TP53 mutations (2020) Egger-Heidrich K, Middeke JM, Schaefer-Eckart K, Kaufmann M, Einsele H, Mueller-Tidow C, Rösler W, et al. Conference contribution „Geriatrie – Herausforderungen im klinischen Alltag“: call for papers (2020) Gosch M, Singler K, Heppner HJ Journal article, Editorial Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases (2020) Berking C, Schadendorf D, Weichenthal M, Eigentler T, Mohr P, Schober K, Kiecker F, et al. Conference contribution Safety analysis of the run-in phase (1st and 2nd cohort) of the IMMUNIB trial (AIO-HEP-0218/ass) - An open-label, single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced stage HCC (2020) Vogel A, Mueller DW, De Toni E, Siegler GM, Lindig U, Mueller T, Schultheiss M, et al. Conference contribution